Imaging & Diagnostics

The fundamental strategy of clinical medicine is shifting from managing symptoms to identifying the earliest molecular indicators of disease. By integrating sophisticated genomic analysis with high-fidelity imaging, practitioners are now able to intercept pathological processes long before they manifest as systemic illness, significantly improving the efficacy of therapeutic interventions.

Serac Healthcare has secured fast track designation from the US Food and Drug Administration for 99mTc-maraciclatide, a SPECT-CT imaging agent developed to visualise inflammation in...

The UK government has launched the National Healthtech Access Programme (NHAP) to improve and standardise access to innovative medical technologies across the National Health Service...

GE HealthCare has launched the ReadyFix fleet management solution in the United States, introducing a remote system designed to help healthcare providers maintain medical device...

Integrating machine learning and predictive tools within clinical environments represents a paradigm shift in medical precision. Modern diagnostic frameworks and automated workflows are fundamentally altering how clinicians identify pathologies and manage patient recovery pathways.

GE HealthCare today announced a collaboration with Diagnoly to advance AI-enabled fetal ultrasound by integrating Diagnoly’s Fetoly solution into GE HealthCare’s Voluson women’s health ultrasound...

GE HealthCare FDA clearance marks a key regulatory milestone for the company’s Allia Moveo interventional imaging system, which has received both U.S. Food and Drug...